|
시장보고서
상품코드
2008906
약물남용 검사 시장 보고서 : 제품별, 검체별, 최종사용자별, 지역별(2026-2034년)Drug Abuse Testing Market Report by Product, Sample (Urine, Oral Fluid, Hair, Breath, and Others), End User, and Region 2026-2034 |
||||||
세계의 약물남용 검사 시장 규모는 2025년에 79억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 126억 달러에 달하며, 2026-2034년에 CAGR 5.36%로 성장할 것으로 예측하고 있습니다.
약물 남용은 불법 약물을 의도적으로 섭취하거나 처방된 향정신성 약물, 성능 향상 약물, 일반의약품(OTC)을 과다 복용하는 것을 말합니다. 이는 심신에 악영향을 미치고 중독 등 다양한 장애를 유발할 수 있습니다. 그 결과, 관련 질환에 대한 효과적인 치료를 제공하기 위해 다양한 검사 방법을 통해 개인이 진단을 받고 있습니다. 약물 남용 검사는 응급실에서의 급성 정신 상태 및 발작 사례 관리, 불법 약물에 노출될 위험이 있는 어린이와 신생아를 식별하는 데도 도움이 됩니다. 현재는 채용 전 직장내 지원자 검사에도 활용되고 있습니다.
약물 남용 검사 시장 동향:
현재 오피오이드, 칸나비노이드, 코카인, 디에틸아미드(LSD), 바르비투르산, 암페타민, 알코올, 디아제팜, 케타민과 같은 약물은 정신 작용, 비치료적 및 비의료적 사용, 체중 감량 및 운동 능력 향상 등 다양한 목적으로 남용되고 있습니다. 남용되고 있습니다. 이는 약물 의존 및 약물 사용 장애로 이어질 수 있으며, 이는 전 세계에서 약물 남용 검사에 대한 수요를 주도하는 주요 요인 중 하나입니다. 약물 남용은 심각한 안전 및 건강상의 위험을 초래하고, 개인의 생산성과 사기를 떨어뜨릴 수 있습니다. 그 결과, 직원 및 구직자 선별, 안전한 작업 환경 보장, 엄격한 정부 법률 및 규정 준수를 위해 약물 남용 테스트의 활용이 촉진되고 있습니다. 또한 통증 관리 및 오피오이드 중독 치료 클리닉이 크게 증가함에 따라 전 세계 소변 약물 검사에 대한 수요가 증가하고 있습니다. 또한 주요 기업은 약물 남용 검사에 대한 자동화된 검사 및 분석 서비스를 제공하고 있습니다. 이 회사들은 가정용 키트를 통한 즉각적인 약물 남용 검사도 제공하고 있습니다. 여기에다 호황을 누리고 있는 E-Commerce 산업이 맞물려 시장 성장을 촉진하고 있습니다.
이 보고서에서 답변하는 주요 질문
- 지금까지의 세계 약물남용 검사 시장의 동향은 어떠했으며, 향후 수년간 어떻게 변화하는가?
- COVID-19는 세계 약물 남용 검사 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 제품별로 보면 시장 내역은?
- 시료별 시장 분석은 어떻게 이루어지고 있는가?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계의 약물 남용 검사 시장의 구조는 무엇이며, 주요 업체는 어디인가?
- 이 업계의 경쟁은 얼마나 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 약물남용 검사 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 샘플별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSAThe global drug abuse testing market size reached USD 7.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.36% during 2026-2034.
Drug abuse is the deliberate consumption of illegal substances or overindulgence of prescribed psychoactive or performance-enhancing chemicals and over-the-counter (OTC) medications. It can affect the mind and body and lead to various disorders like addiction. As a result, it is diagnosed among individuals using different testing methods to provide effective treatment for related disorders. Drug abuse testing also assists in managing acute mental status and seizure cases in the emergency room and identifying children and newborns at risk of exposure to illicit drugs. Nowadays, it finds application in workplaces before hiring an applicant.
DRUG ABUSE TESTING MARKET TRENDS:
Presently, drugs like opiates, cannabinoids, cocaine, lysergic acid diethylamide (LSD), barbiturates, amphetamines, alcohol, diazepam, and ketamine are abused for their mind-altering characteristics, non-therapeutic and medicinal uses, and other purposes, including weight loss and enhancing athletic performance. This can lead to drug dependence and substance use disorder , which represents one of the key factors driving the demand for drug abuse testing across the globe. Apart from this, drug abuse can create significant safety and health hazards and decrease the productivity and morale of an individual. This, in turn, is positively influencing the use of drug abuse testing to screen employees and job applicants, provide a safe workplace, and comply with strict government laws and regulations. Moreover, substantial growth in pain management and opioid dependency clinics is catalyzing the demand for urine drug testing worldwide. Furthermore, leading companies are offering automated testing and analysis for drugs of abuse. These companies are also offering at-home use kits for instant drug abuse tests. This, along with the thriving e-commerce industry, is impelling the growth of the market.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Analyzers
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
- Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Laboratory Services
Breakup by Sample:
- Urine
- Oral Fluid (Saliva)
- Hair
- Breath
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Forensic Laboratories
- Workplaces
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Omega Laboratories Inc., Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc. and United States Drug Testing Laboratories Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global drug abuse testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global drug abuse testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the sample?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global drug abuse testing market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Drug Abuse Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Analyzers
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Immunoassays Analyzers
- 6.1.2.2 Chromatographic Devices
- 6.1.2.3 Breath Analyzers
- 6.1.3 Market Forecast
- 6.2 Rapid Testing Devices
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Urine Testing Devices
- 6.2.2.2 Oral Fluid Testing Devices
- 6.2.3 Market Forecast
- 6.3 Consumables
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Laboratory Services
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Sample
- 7.1 Urine
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Oral Fluid (Saliva)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Hair
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Breath
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diagnostic Laboratories
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Forensic Laboratories
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Workplaces
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Bio-Rad Laboratories Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Danaher Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Dragerwerk AG & Co. KGaA
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 F. Hoffmann-La Roche AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 SWOT Analysis
- 14.3.6 Laboratory Corporation of America Holdings
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Omega Laboratories Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Quest Diagnostics Incorporated
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Siemens AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Thermo Fisher Scientific Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 United States Drug Testing Laboratories Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.1 Abbott Laboratories
